These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 25288153)
1. Stress Conditions Increase Vimentin Cleavage by Omi/HtrA2 Protease in Human Primary Neurons and Differentiated Neuroblastoma Cells. Lucotte B; Tajhizi M; Alkhatib D; Samuelsson EB; Wiehager B; Schedin-Weiss S; Sundström E; Winblad B; Tjernberg LO; Behbahani H Mol Neurobiol; 2015 Dec; 52(3):1077-1092. PubMed ID: 25288153 [TBL] [Abstract][Full Text] [Related]
2. Enhanced HtrA2/Omi expression in oxidative injury to retinal pigment epithelial cells and murine models of neurodegeneration. Ding X; Patel M; Shen D; Herzlich AA; Cao X; Villasmil R; Klupsch K; Tuo J; Downward J; Chan CC Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4957-66. PubMed ID: 19443712 [TBL] [Abstract][Full Text] [Related]
3. Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy. Wang P; Hu Y; Yao D; Li Y Cell Physiol Biochem; 2018; 49(6):2163-2173. PubMed ID: 30286467 [TBL] [Abstract][Full Text] [Related]
4. Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells. Pruefer FG; Lizarraga F; Maldonado V; Melendez-Zajgla J J Chemother; 2008 Jun; 20(3):348-54. PubMed ID: 18606591 [TBL] [Abstract][Full Text] [Related]
5. THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death. Balakrishnan MP; Cilenti L; Mashak Z; Popat P; Alnemri ES; Zervos AS Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H643-53. PubMed ID: 19502560 [TBL] [Abstract][Full Text] [Related]
6. Omi/HtrA2 protease is associated with tubular cell apoptosis and fibrosis induced by unilateral ureteral obstruction. Kim J; Kim DS; Park MJ; Cho HJ; Zervos AS; Bonventre JV; Park KM Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1332-40. PubMed ID: 20219823 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2. Cilenti L; Lee Y; Hess S; Srinivasula S; Park KM; Junqueira D; Davis H; Bonventre JV; Alnemri ES; Zervos AS J Biol Chem; 2003 Mar; 278(13):11489-94. PubMed ID: 12529364 [TBL] [Abstract][Full Text] [Related]
8. Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212. Yang L; Sun M; Sun XM; Cheng GZ; Nicosia SV; Cheng JQ J Biol Chem; 2007 Apr; 282(15):10981-7. PubMed ID: 17311912 [TBL] [Abstract][Full Text] [Related]
9. Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1. Kieper N; Holmström KM; Ciceri D; Fiesel FC; Wolburg H; Ziviani E; Whitworth AJ; Martins LM; Kahle PJ; Krüger R Exp Cell Res; 2010 Apr; 316(7):1213-24. PubMed ID: 20064504 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Omi/HtrA2 Promotes Caspase Activation Through Cleavage of HAX-1 in Aging Heart. Liu X; Lei J; Wang K; Ma L; Liu D; Du Y; Wu Y; Zhang S; Wang W; Ma X; Liu H Rejuvenation Res; 2017 Jun; 20(3):183-192. PubMed ID: 27998213 [TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. Park HJ; Kim SS; Seong YM; Kim KH; Goo HG; Yoon EJ; Min do S; Kang S; Rhim H J Biol Chem; 2006 Nov; 281(45):34277-87. PubMed ID: 16968707 [TBL] [Abstract][Full Text] [Related]
12. Translocation of the serine protease Omi/HtrA2 from mitochondria into the cytosol upon seizure-induced hippocampal injury in the neonatal rat brain. Rami A; Kim M; Niquet J Neurochem Res; 2010 Dec; 35(12):2199-207. PubMed ID: 21132459 [TBL] [Abstract][Full Text] [Related]
13. Increased Active OMI/HTRA2 Serine Protease Displays a Positive Correlation with Cholinergic Alterations in the Alzheimer's Disease Brain. Darreh-Shori T; Rezaeianyazdi S; Lana E; Mitra S; Gellerbring A; Karami A; Bogdanovic N; Lithner CU; Winblad B; Behbahani H Mol Neurobiol; 2019 Jul; 56(7):4601-4619. PubMed ID: 30361890 [TBL] [Abstract][Full Text] [Related]
14. The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion. Althaus J; Siegelin MD; Dehghani F; Cilenti L; Zervos AS; Rami A Neurochem Int; 2007 Jan; 50(1):172-80. PubMed ID: 16978742 [TBL] [Abstract][Full Text] [Related]
15. Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2. Srinivasula SM; Gupta S; Datta P; Zhang Z; Hegde R; Cheong N; Fernandes-Alnemri T; Alnemri ES J Biol Chem; 2003 Aug; 278(34):31469-72. PubMed ID: 12835328 [TBL] [Abstract][Full Text] [Related]
16. HtrA2/Omi is involved in 6-OHDA-induced endoplasmic reticulum stress in SH-SY5Y cells. Luo F; Wei L; Sun C; Chen X; Wang T; Li Y; Liu Z; Chen Z; Xu P J Mol Neurosci; 2012 May; 47(1):120-7. PubMed ID: 22246992 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial serine protease Omi/HtrA2 accentuates brain ischemia/reperfusion injury in rats and oxidative stress injury in vitro by modulating mitochondrial stress proteins CHOP and ClpP and physically interacting with mitochondrial fusion protein OPA1. You H; Jin Y; Kang J; Mao Y; Su J; Sun L; Wang L; Meng H Bioengineered; 2020 Dec; 11(1):1058-1070. PubMed ID: 33016225 [TBL] [Abstract][Full Text] [Related]
18. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion. Liu HR; Gao E; Hu A; Tao L; Qu Y; Most P; Koch WJ; Christopher TA; Lopez BL; Alnemri ES; Zervos AS; Ma XL Circulation; 2005 Jan; 111(1):90-6. PubMed ID: 15611365 [TBL] [Abstract][Full Text] [Related]
19. Cardiac Specific Overexpression of Mitochondrial Omi/HtrA2 Induces Myocardial Apoptosis and Cardiac Dysfunction. Wang K; Yuan Y; Liu X; Lau WB; Zuo L; Wang X; Ma L; Jiao K; Shang J; Wang W; Ma X; Liu H Sci Rep; 2016 Dec; 6():37927. PubMed ID: 27924873 [TBL] [Abstract][Full Text] [Related]
20. Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease. Westerlund M; Behbahani H; Gellhaar S; Forsell C; Belin AC; Anvret A; Zettergren A; Nissbrandt H; Lind C; Sydow O; Graff C; Olson L; Ankarcrona M; Galter D FASEB J; 2011 Apr; 25(4):1345-52. PubMed ID: 21163861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]